Back to Journals » Infection and Drug Resistance » Volume 9

Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum]

Authors Rustomjee R, Zumla A

Received 24 November 2015

Accepted for publication 24 November 2015

Published 1 April 2016 Volume 2016:9 Pages 43—45

DOI https://doi.org/10.2147/IDR.S101190


Rustomjee R, Zumla A. Delamanid expanded access novel treatment of drug resistant tuberculosis. Infection and Drug Resistance. 2015;8:359–366.
 
Dr Rustomjee and Professor Zumla are grateful to a reader for raising some issues regarding referencing, and interpretation of their paper, and would like to clarify and address these issues.
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]